We first determined the FLT3 and AKT protein levels in luekemia cell lines before mitoxantrone-liposomes treatment (Fig. 3a), then determined the FLT3 protein levels in the leukemia cell lines 12 h post-treatment with mitoxantrone-liposomes (Fig. 3b). The gene discussed is AKT1; the disease is leukemia.